CHAI, with support from Unitaid
, is working to scale up safe, effective, and affordable cervical cancer screening and treatment of pre-cancerous lesions across our partner countries. We are working to reach more women by leveraging existing platforms to offer tools that are available but not widely used: HPV testing for screening and portable thermal ablation devices to treat pre-cancerous lesions. We are using CHAI’s market-shaping experience to bring promising new products and technologies to market to ensure the sustainable, affordable, and timely supply of screening and treatment tools as well as HPV tests.
At the same time, we are testing integrated models to reach women living with HIV through existing health services, such as treatment clinics; reaching women in the general population through family planning services; and offering HPV testing on multiplex diagnostic platforms that are being underutilized for other testing.